Kidney disease in cirrhosis is now viewed as a continuum encompassing acute kidney injury (AKI), acute kidney disease (AKD), and chronic kidney disease (CKD), rather than three different disorders. Contemporary diagnostic criteria for AKI integrate urine output (UO) parameters and acknowledge the intricate relationship and possibility of overlap between functional and structural as well as acute and chronic entities, including hepatorenal syndrome (HRS). AKI demonstrates a propensity for progression to AKD and CKD, particularly in the context of recurrent and severe insults. The diagnostic complexity is further compounded by limitations in serum creatinine measurements, prompting the integration of novel biomarkers and the need to accurately estimate glomerular filtration rate. The diagnosis, phenotyping, and management of AKI should be prompt and early; the initial step should always be volume and UO assessment. A personalized approach is needed and the possibility of co-existing structural or functional kidney disease should be borne in mind. The earlier concept of waiting for 48 hours to diagnose HRS has evolved and early diagnosis and prompt treatment are advised now. Kidney replacement therapy and simultaneous liver and kidney transplantation may be required in resistant cases.
Citations
Citations to this article as recorded by
Comprehensive Conservative Management Versus Dialysis in Uric Acid Control Francesca K. Martino, Greta Redi, Marco Bogo, Elena Sgrò, Alessandra Zattarin, Giovanni Samassa, Lucia Federica Stefanelli, Anna Basso, Federico Nalesso Dietetics.2026; 5(1): 9. CrossRef
Association between the C-reactive protein–triglyceride–glucose index (CTI) and the risk of acute kidney injury in critically ill patients with cirrhosis Lu-Huai Feng, Tianbao Liao, Tingting Su, Xuefei Zhou, Yang Lu, Lina Huang, Zhenhua Yang BMC Nephrology.2025;[Epub] CrossRef
Ji Hyun Kim, Baek Gyu Jun, Minjong Lee, Hye Ah Lee, Tae Suk Kim, Jeong Won Heo, Da Hye Moon, Seong Hee Kang, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim, Dae Hee Choi
Clin Mol Hepatol 2022;28(3):540-552. Published online May 6, 2022
Background/Aims Sepsis-3 criteria and quick Sequential Organ Failure Assessment (qSOFA) have been advocated to be used in defining sepsis in the general population. We aimed to compare the Sepsis-3 criteria and Chronic Liver Failure-SOFA (CLIF-SOFA) scores as predictors of in-hospital mortality in cirrhotic patients admitted to the emergency department (ED) for infections.
Methods A total of 1,622 cirrhosis patients admitted at the ED for infections were assessed retrospectively. We analyzed their demographic, laboratory, and microbiological data upon diagnosis of the infection. The primary endpoint was inhospital mortality rate. The predictive performances of baseline CLIF-SOFA, Sepsis-3, and qSOFA scores for in-hospital mortality were evaluated.
Results The CLIF-SOFA score proved to be significantly better in predicting in-hospital mortality (area under the receiver operating characteristic curve [AUROC], 0.80; 95% confidence interval [CI], 0.78–0.82) than the Sepsis-3 (AUROC, 0.75; 95% CI, 0.72–0.77, P<0.001) and qSOFA (AUROC, 0.67; 95% CI, 0.64–0.70; P<0.001) score. The CLIF-SOFA, CLIF-C-AD scores, Sepsis-3 criteria, septic shock, and qSOFA positivity were significantly associated with in-hospital mortality (adjusted hazard ratio [aHR], 1.24; 95% CI, 1.19–1.28; aHR, 1.13; 95% CI, 1.09–1.17; aHR, 1.19; 95% CI, 1.15–1.24; aHR, 1.88; 95% CI, 1.42–2.48; aHR, 2.06; 95% CI, 1.55–2.72; respectively; all P<0.001). For CLIF-SOFA scores ≥6, in-hospital mortality was >10%; this is the cutoff point for the definition of sepsis.
Conclusions Among cirrhosis patients presenting with infections at the ED, CLIF-SOFA scores showed a better predictive performance for mortality than both Sepsis-3 criteria and qSOFA scores, and can be a useful tool of risk stratification in cirrhotic patients requiring timely intervention for infection.
Citations
Citations to this article as recorded by
Interpretable model for early prediction of 28-day mortality in patients with cirrhosis and sepsis: a multi-cohort ICU study Xin Xu, Jingjing Li, Haijing Yu, Jiaquan Huang BMC Gastroenterology.2026;[Epub] CrossRef
A Serum DLL1 and CRP dual-marker model for bacterial infection detection in patients with decompensated cirrhosis: A dual-cohort diagnostic study Juanjun Huang, Luhu Yu, Debin Zeng, Yulin Wang, Zhi Wang, Jian Chen, Wei Zhu Science Progress.2025;[Epub] CrossRef
Correlation between systemic inflammatory response syndrome and prognosis of patients with cirrhosis and hepatic encephalopathy Kaiyue Zhang, Ziqun Qu, Rongyu Tang, Hongliang Dong, Jing Fan, Wei Ye BMC Gastroenterology.2025;[Epub] CrossRef
Management of patients with cirrhosis in the emergency department: Implications for hospitalization outcomes Sandeep Sikerwar, Sohrab Zand, Peter Steel, Arun Jesudian Liver Transplantation.2024; 30(1): 94. CrossRef
Current Status of Prognostic Evaluation Model and Treatment of Acute-on-Chronic Liver Failure 念 刘 Advances in Clinical Medicine.2024; 14(04): 2500. CrossRef
Prevalence and predictors of multidrug-resistant bacteremia in liver cirrhosis Aryoung Kim, Byeong Geun Song, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Myung Ji Goh The Korean Journal of Internal Medicine.2024; 39(3): 448. CrossRef
Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-ju Yoo, Sang Gyune Kim, Moon Young Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Jin Mo Ya Clinical and Molecular Hepatology.2024; 30(3): 388. CrossRef
Correspondence to editorial on “Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment” Do Seon Song, Dong Joon Kim Clinical and Molecular Hepatology.2024; 30(4): 1012. CrossRef
Cirrhosis Management in the Intensive Care Unit Thomas N. Smith, Alice Gallo de Moraes, Douglas A. Simonetto Seminars in Liver Disease.2023; 43(01): 117. CrossRef
From Liver to Brain: A 2.5D Deep Learning Model for Predicting Hepatic Encephalopathy Using Opportunistic Non-contrast CT in Hepatitis B Related Acute-on-Chronic Liver Failure Patients Zonglin Liu, Xueyun Zhang, Ying Chen, Qi Zhang, Zhenxuan Ma, Yue Wu, Yuxin Huang, Yajie Li, Xi Zhao, Wenchao Gu, Jiaxing Wu, Ying Tao, Yuxin Shi, Zhenwei Yao, Yan Ren, Yuxian Huang, Shiman Wu Journal of Imaging Informatics in Medicine.2026;[Epub] CrossRef
Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases Jongman Kim, Sang Jin Kim, Boram Park, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Seung Heui Hong, Soon-Young Kim, Jungbun Park, Youngwon Hwang, Dong-Hwan Jung Journal of Korean Medical Science.2026;[Epub] CrossRef
Emergency living donor liver transplantation Jongman Kim Annals of Liver Transplantation.2025; 5(1): 27. CrossRef
RAC1 as a novel therapeutic target for acute liver failure Barbara Bueloni, Esteban Fiore, María José Cantero, Lucia Lameroli, Catalina Atorrasagasti, Matías Ciarlantini, Andrea Barquero, Lucía Gandolfi Donadio, Daiana Ganiewich, Francisco Orozco, Martín Fauda, Julieta Comin, Ali Canbay, Juan Bayo, Guillermo Mazz JHEP Reports.2025; 7(11): 101547. CrossRef
Akkermansia muciniphila improve cognitive dysfunction by regulating BDNF and serotonin pathway in gut-liver-brain axis Eun Ji Kang, Min-Gi Cha, Goo-Hyun Kwon, Sang Hak Han, Sang Jun Yoon, Sang Kyu Lee, Moo Eob Ahn, Sung-Min Won, Eun Hee Ahn, Ki Tae Suk Microbiome.2024;[Epub] CrossRef
Gut microbiome and metabolome signatures in liver cirrhosis-related complications Satya Priya Sharma, Haripriya Gupta, Goo-Hyun Kwon, Sang Yoon Lee, Seol Hee Song, Jeoung Su Kim, Jeong Ha Park, Min Ju Kim, Dong-Hoon Yang, Hyunjoon Park, Sung-Min Won, Jin-Ju Jeong, Ki-Kwang Oh, Jung A Eom, Kyeong Jin Lee, Sang Jun Yoon, Young Lim Ham, G Clinical and Molecular Hepatology.2024; 30(4): 845. CrossRef
Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: a randomized placebo-controlled trial Haifeng Lu, Xiaofei Zhu, Lingyun Wu, Xiaobin Lou, Xiaxia Pan, Bowen Liu, Hua Zhang, Lingxiao Zhu, Lanjuan Li, Zhongwen Wu Frontiers in Microbiology.2023;[Epub] CrossRef
Patients with cirrhosis are susceptible to develop infections because of immune dysfunction, changes in microbiome and increase in bacterial translocation from the gut to systemic circulation. Bacterial infections can worse the clinical course of the disease, triggering the development of complications such as acute kidney injury, hepatic encephalopathy, organ failures and acute on chronic liver failure. In recent years, the spread of multi drug resistant bacteria made more challenging the management of infections in patients with cirrhosis. Hence, the mortality rate associated to sepsis is increasing in these patients. Therefore, the optimization of the management of infections has a high priority in cirrhosis. Herein we reviewed the recent changes in the epidemiology and the management of bacterial infections in patients with liver cirrhosis.
Citations
Citations to this article as recorded by
Impact of Serious Infection on Mortality of Patients With Chronic Liver Disease: A Nationwide Population-based Cohort Study Jae Yoon Jeong, Ju-Yeon Cho, Danbee Kang, Jung Hee Kim, Soo Jin Park, Eun-Jeong Joo, Hyunwoo Oh, Yong Kyun Cho, Byung Ik Kim, Won Sohn Clinical Gastroenterology and Hepatology.2026; 24(2): 443. CrossRef
Global Trends in Antimicrobial Resistance Among Cirrhosis Patients With Bacteremia: A Systematic Review and Meta-analysis Ellis K. Paintsil, Cynthia K. Adu-Asiamah, Victoria T. Kronsten, Yevedzo Ntuli, Debbie L. Shawcross Clinical Gastroenterology and Hepatology.2026; 24(1): 69. CrossRef
Prospective surveillance reveals high rates of antimicrobial resistance in urinary tract infections among patients with cirrhosis. Carolina Vazquez, Gonzalo Gómez Perdiguero, Esteban González Ballerga, Ilse Pardo Ivirico, Camila M. Briz, Agustín Di Santo, Maria D. Murga, Ana Palazzo, Lorena Notari, Josefina Pages, Julia Brutti, Brenda Osso Sánchez, Manuel Mendizabal, Margarita Anders Annals of Hepatology.2026; 31(1): 102135. CrossRef
Interpretable model for early prediction of 28-day mortality in patients with cirrhosis and sepsis: a multi-cohort ICU study Xin Xu, Jingjing Li, Haijing Yu, Jiaquan Huang BMC Gastroenterology.2026;[Epub] CrossRef
Factors Associated with Death in Patients with Liver Cirrhosis at Tengandogo University Hospital Center Sandrine Marie-Odile Bobilwindé Soudré, Micael Balima, Aïssatou Ouédraogo, Hakani Nathalie Beni, Nafissatou Balima, Mouniratou Balima, Aboubacar Coulibaly, Nanelin Alice Guingane, Steve Léonce Zoungrana, Rodrigue Salou, Sosthène Somda, Arsène Roger Sombié Open Journal of Gastroenterology.2026; 16(01): 57. CrossRef
Towards evidence-based empiric antibiotic recommendations for spontaneous infections in patients with cirrhosis Melisa Dirchwolf, Gonzalo Gomez Perdiguero, Fernando Cairo, Carolina Vazquez, Lorena Notari, Maria Dolores Murga, Martin Elizondo, Fernando Bessone, Marina Agozino, Julia Brutti, Alina Raquel Zerega, Josefina Pages, Teodoro Eduardo Stieben, Pablo Calzetta Digestive and Liver Disease.2025; 57(2): 394. CrossRef
Higher Rate of Spontaneous Bacterial Peritonitis Recurrence With Secondary Spontaneous Bacterial Peritonitis Prophylaxis Compared With No Prophylaxis in 2 National Cirrhosis Cohorts Scott Silvey, Nilang R. Patel, Stephanie Y. Tsai, Mahum Nadeem, Richard K. Sterling, John D. Markley, Evan French, Jacqueline G. O'Leary, Jasmohan S. Bajaj American Journal of Gastroenterology.2025; 120(5): 1066. CrossRef
Bacterial resistance profile and its association with poor outcome among cirrhosis patients attending a tertiary care referral center in northern India Gerlin Varghese, Ashima Jamwal, Deepika Sarawat, Surender Singh, Nidhi Tejan, Sangram Singh Patel, Chinmoy Sahu Indian Journal of Gastroenterology.2025; 44(2): 198. CrossRef
Lactate-to-albumin ratio as a potential prognostic predictor in patients with cirrhosis and sepsis: a retrospective cohort study Jianjun Wang, Xi Chen, Chuan Qin, Ruizi Shi, Yu Huang, Jianping Gong, Xintao Zeng, Decai Wang BMC Infectious Diseases.2025;[Epub] CrossRef
A Case of Complicated Bacteremia: When the Source Is in the Blood Raquel Costeira, Elisa Macedo Brás, Ricardo Manuel Pereira, Inês Barbosa Leão, Catia Canelas Cureus.2025;[Epub] CrossRef
Relationship between coagulopathy score and survival in critically ill patients with liver cirrhosis and sepsis: a retrospective study Tao Wang, Decai Wang, Ruizi Shi, Xintao Zeng, Pei Yang, Xi Chen, Sirui Chen, Chuan Qin, Chidan Wan, Jianjun Wang BMC Infectious Diseases.2025;[Epub] CrossRef
Infection risk and management in patients with cirrhosis: A critical overview Miguel Suárez, Raquel Martínez, Raquel Gómez-Molina, Jorge Mateo World Journal of Hepatology.2025;[Epub] CrossRef
A National Survey Shows a Dilemma Toward Spontaneous Bacterial Peritonitis Prophylaxis Among US-Based Hepatology Professionals Deborah DiazGranados, Jacqueline G. O'Leary, Madhumita Yamuzala, Shari Rogal, Jasmohan S. Bajaj Clinical and Translational Gastroenterology.2025; 16(7): e00858. CrossRef
A Serum DLL1 and CRP dual-marker model for bacterial infection detection in patients with decompensated cirrhosis: A dual-cohort diagnostic study Juanjun Huang, Luhu Yu, Debin Zeng, Yulin Wang, Zhi Wang, Jian Chen, Wei Zhu Science Progress.2025;[Epub] CrossRef
Predictive role of the Albumin-Bilirubin score in ICU patients with cirrhosis and sepsis: insights from a large retrospective cohort Jianjun Wang, Pei Yang, Chuan Qin, Yongwei Huang, Zhaohui Hu, Ruizi Shi, Sirui Chen, Xi Chen, Hua Luo, Jianping Gong, Xintao Zeng, Decai Wang BMC Gastroenterology.2025;[Epub] CrossRef
Associations of lactate-to-hematocrit ratio with short- and long-term prognoses in critically ill patients with cirrhosis and sepsis: a retrospective cohort study Jianjun Wang, Xi Chen, Sirui Chen, Zhaohui Hu, Yancheng Liu, Ruizi Shi, Chuan Qin, Jianping Gong, Xintao Zeng, Decai Wang BMC Infectious Diseases.2025;[Epub] CrossRef
Machine learning-based nomogram for mortality risk stratification in cirrhotic patients with sepsis: a single-center predictive model Xing-Cheng Zhang, Bo-Wen Li, Xi-Qun Lei, Nan-Bing Shan, Jun-Ping Wei, Zhong-Hua Lu, Yun Sun Frontiers in Medicine.2025;[Epub] CrossRef
Pre‐transplant multidrug‐resistant infections in liver transplant recipients‐epidemiology and impact on transplantation outcome Gabriela T. Lemos, Debora R. B. Terrabuio, Nathalia N. Nunes, Alice T. W. Song, Isabel C. V. Oshiro, Luiz Augusto C. D'Albuquerque, Anna S. Levin, Edson Abdala, Maristela P. Freire Clinical Transplantation.2024;[Epub] CrossRef
Identifying hub genes of sepsis-associated and hepatic encephalopathies based on bioinformatic analysis—focus on the two common encephalopathies of septic cirrhotic patients in ICU Juan Li, Dong Yang, Shengmei Ge, Lixia Liu, Yan Huo, Zhenjie Hu BMC Medical Genomics.2024;[Epub] CrossRef
Kidney pathology in liver cirrhosis E. G. Malaeva Health and Ecology Issues.2024; 20(4): 70. CrossRef
Navigating the Labyrinth: Intensive Care Challenges for Patients with Acute-on-Chronic Liver Failure Fuat H. Saner, Dimitri A. Raptis, Saad A. Alghamdi, Massimo M. Malagó, Dieter C. Broering, Dmitri Bezinover Journal of Clinical Medicine.2024; 13(2): 506. CrossRef
High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study Jun Sik Yoon, Ji Hoon Hong, Soo Young Park, Seung Up Kim, Hwi Young Kim, Ju Yeon Kim, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Han Ah Lee, Gi‐Ae Kim, Dong Hyun Sinn, Sung Jae Park, Youn Jae Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee Alimentary Pharmacology & Therapeutics.2024; 59(8): 973. CrossRef
Pulmonary Bacterial Infection and Liver Cirrhosis: Current Status and Treatment Yingying Zhao, Song Yang, Huichun Xing Infectious Microbes and Diseases.2024; 6(1): 5. CrossRef
Retrospective study of the incidence, risk factors, treatment outcomes of bacterial infections at uncommon sites in cirrhotic patients Sophie Schneitler, Christina Schneider, Markus Casper, Frank Lammert, Marcin Krawczyk, Sören L Becker, Matthias Christian Reichert World Journal of Hepatology.2024; 16(3): 418. CrossRef
Infectious Complications of Portal Hypertension Simone Incicco, Paolo Angeli, Salvatore Piano Clinics in Liver Disease.2024; 28(3): 525. CrossRef
Development of a nomogram for predicting in-hospital mortality in patients with liver cirrhosis and sepsis Hai-rong Lin, Qiu-xia Liao, Xin-xin Lin, Ye Zhou, Jian-dong Lin, Xiong-jian Xiao Scientific Reports.2024;[Epub] CrossRef
Review article: Evaluation and care of the critically ill patient with cirrhosis Iva Kosuta, Madhumita Premkumar, K. Rajender Reddy Alimentary Pharmacology & Therapeutics.2024; 59(12): 1489. CrossRef
Updates in characteristics and survival rates of cirrhosis in a nationwide cohort of real‐world U.S. patients, 2003–2021 Sally Tran, Biyao Zou, KeeSeok Lee, Leslie Kam, YeeHui Yeo, Linda Henry, Ramsey Cheung, Mindie H. Nguyen Alimentary Pharmacology & Therapeutics.2024; 60(2): 212. CrossRef
Prevalence and predictors of multidrug-resistant bacteremia in liver cirrhosis Aryoung Kim, Byeong Geun Song, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Myung Ji Goh The Korean Journal of Internal Medicine.2024; 39(3): 448. CrossRef
Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy Francisco Idalsoaga, Camila Robles, Andrea Ortiz, Oscar Corsi, Eduardo Fuentes-López, Luis Antonio Díaz, Gustavo Ayares, Marco Arrese, Juan Pablo Arab Therapeutic Advances in Gastroenterology.2024;[Epub] CrossRef
Protocolo terapéutico de las infecciones bacterianas en la cirrosis C. Meruéndano Padrón, J. Donate Ortega, C. García Huerta, M.Á. Rodríguez Gandía Medicine - Programa de Formación Médica Continuada Acreditado.2024; 14(10): 581. CrossRef
Prognostic value of the neutrophil to lymphocyte ratio in the clinical course of liver cirrhosis M. R. Sarkarova, M. V. Maevskaya Meditsinskiy sovet = Medical Council.2024; (8): 66. CrossRef
Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine Shihao Zheng, Chengyuan Xue, Size Li, Xiaobin Zao, Xiaoke Li, Qiyao Liu, Xu Cao, Wei Wang, Wenying Qi, Hongbo Du, Peng Zhang, Yongan Ye Frontiers in Pharmacology.2024;[Epub] CrossRef
Increased serum albumin corrected anion gap levels are associated with poor prognosis in septic patients with liver cirrhosis Zetao Pan, Jiancheng Lin, Cunyang Huo, Di Yin, Qiang Guo Scientific Reports.2024;[Epub] CrossRef
Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: A prospective study Helena Masnou, Ariadna Aguilar, Ignacio Iborra, Margarita Sala, Maria Torner, Ariadna Clos-Parals, Alba Ardèvol, Montserrat Giménez, Marta Fortuny, Maria Rosa Sarrias, Rosa M. Morillas, Eugeni Domènech Gastroenterología y Hepatología.2023; 46(4): 288. CrossRef
Impact of multidrug resistance on the management of bacterial infections in cirrhosis Carlos Terra, Ângelo Zambam de Mattos, Marcelo Souza Chagas, Andre Torres, Denusa Wiltgen, Barbara Muniz Souza, Renata Mello Perez World Journal of Clinical Cases.2023; 11(3): 534. CrossRef
Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution Daniele Bellafante, Stefania Gioia, Jessica Faccioli, Oliviero Riggio, Lorenzo Ridola, Silvia Nardelli Journal of Clinical Medicine.2023; 12(3): 1187. CrossRef
Infection prevention and control programme and COVID-19 measures: Effects on hospital-acquired infections in patients with cirrhosis Simone Di Cola, Jakub Gazda, Lucia Lapenna, Giancarlo Ceccarelli, Manuela Merli JHEP Reports.2023; 5(5): 100703. CrossRef
The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications Ulrich Wirth, Tianxiao Jiang, Josefine Schardey, Katharina Kratz, Mingming Li, Malte Schirren, Florian Kühn, Alexandr Bazhin, Jens Werner, Markus Guba, Christian Schulz, Joachim Andrassy International Journal of Molecular Sciences.2023; 24(5): 4841. CrossRef
Challenges and recommendations when selecting empirical antibiotics in patients with cirrhosis Melisa Dirchwolf, Gonzalo Gomez Perdiguero, Ingrid Mc Grech, Sebastian Marciano World Journal of Hepatology.2023; 15(3): 377. CrossRef
Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay Carolina Vazquez, María Nelly Gutierrez-Acevedo, Sabrina Barbero, Lorena del Carmen Notari, Marina Agozino, José Luis Fernandez, María Margarita Anders, Nadia Lorena Grigera, Florencia Antinucci, Orlando Nicolas Federico Orozco-Ganem, María Dolores Murga, Annals of Hepatology.2023; 28(4): 101097. CrossRef
Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis Valeria Maccauro, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili Life.2023; 13(4): 991. CrossRef
Bacterial Infections in Acute on Chronic Liver Failure Simone Incicco, Paolo Angeli, Salvatore Piano Clinics in Liver Disease.2023; 27(3): 703. CrossRef
Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan Masayuki Ueno, Takashi Fujiwara, Hironobu Tokumasu, Toshifumi Mano, Takahisa Kayahara, Hiroyuki Takabatake, Youichi Morimoto, Kazuhiro Matsueda, Toshio Fukuoka, Motowo Mizuno Journal of Gastroenterology.2023; 58(8): 766. CrossRef
Incidence, risk factors and clinical outcomes of multidrug-resistant microorganism infections among patients admitted for decompensated cirrhosis: A prospective study Helena Masnou, Ariadna Aguilar, Ignacio Iborra, Margarita Sala, Maria Torner, Ariadna Clos-Parals, Alba Ardèvol, Montserrat Giménez, Marta Fortuny, Maria Rosa Sarrias, Rosa M. Morillas, Eugeni Domènech Gastroenterología y Hepatología (English Edition).2023; 46(4): 288. CrossRef
Management of sepsis in a cirrhotic patient admitted to the intensive care unit: A systematic literature review Nkola Ndomba, Jonathan Soldera World Journal of Hepatology.2023; 15(6): 850. CrossRef
Antibiotic resistance in patients with liver cirrhosis: Prevalence and current approach to tackle Valentina Liakina World Journal of Clinical Cases.2023; 11(31): 7530. CrossRef
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany Wolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, Esmeralda Ismail, Vasiliki Kalampoka, Max Hilscher, Maurice Michel, Ekkehard Siegel, Jörn M. Schattenberg, Peter R. Galle, Martin F. Sprinzl, Marcus-Alexander Wörns, Michael Nagel, Christia Annals of Hepatology.2022; 27(5): 100719. CrossRef
Management of Multidrug-Resistant Infections in Cirrhosis Charles E. Gallaher, Debbie L. Shawcross Seminars in Liver Disease.2022; 42(02): 173. CrossRef
Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study Ji Hyun Kim, Baek Gyu Jun, Minjong Lee, Hye Ah Lee, Tae Suk Kim, Jeong Won Heo, Da Hye Moon, Seong Hee Kang, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim, Dae Hee Choi Clinical and Molecular Hepatology.2022; 28(3): 540. CrossRef
Real‐world clinical features, health‐care utilization, and economic burden in decompensated cirrhosis patients: A national database Hankil Lee, Beom Kyung Kim Journal of Gastroenterology and Hepatology.2022; 37(11): 2154. CrossRef
Early Diagnosis and Prevention of Infections in Cirrhosis Anand V. Kulkarni, Madhumita Premkumar, Juan P. Arab, Karan Kumar, Mithun Sharma, Nageshwar D. Reddy, Nagaraja R. Padaki, Rajender K. Reddy Seminars in Liver Disease.2022; 42(03): 293. CrossRef
Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun Clinical and Molecular Hepatology.2022; 28(4): 876. CrossRef
New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease Hankil Lee, Jeong-Ju Yoo, Sang Hoon Ahn, Beom Kyung Kim Clinical and Translational Gastroenterology.2022; 13(12): e00542. CrossRef
Antibiotics and Liver Cirrhosis: What the Physicians Need to Know Caterina Zoratti, Rita Moretti, Lisa Rebuzzi, Irma Valeria Albergati, Antonietta Di Somma, Giuliana Decorti, Stefano Di Bella, Lory Saveria Crocè, Mauro Giuffrè Antibiotics.2021; 11(1): 31. CrossRef
Bacterial Infections in Cirrhosis Marta Tonon, Paolo Angeli, Salvatore Piano Infectious Microbes and Diseases.2021; 3(3): 117. CrossRef
Hepatic encephalopathy and spontaneous bacterial peritonitis are associated with increased liver-related readmissions in cirrhosis Shan Wang, Lin Zhang, Jin Li, Jiajun Feng, Jie Gao, Rui Huang Frontiers in Medicine.2025;[Epub] CrossRef
Global burden of cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2021 Ying Zhang, Ming Luo, Yingzi Ming BMC Gastroenterology.2025;[Epub] CrossRef
Role of MicroRNAs in Alcohol-Related Liver Disease Prabhudas Nelaturi, Sangeetha P Kademani, Krishna Sumanth Nallagangula, Sambandam Ravikumar Alcoholism Treatment Quarterly.2024; 42(1): 115. CrossRef
Burden of caregiving of alcohol related liver disease patients: a possible role of training and caregiver groups frequency. Proposal of a method, preliminary results Patrizia BALBINOT, Rinaldo PELLICANO, Gianni TESTINO Minerva Gastroenterology.2024;[Epub] CrossRef
Metabolomics in cirrhosis: Recent advances and opportunities Yan-qun Luo, Cai-yun Zhang, Xia-zhen Nong, Ying Gao, Lei Wang, Guang Ji, Tao Wu Clinica Chimica Acta.2024; 557: 117886. CrossRef
Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis Keon Hwi Im, Waqar Khalid Saeed, Eun Bin Kim, A. Hyeon Lee, Ji Eun Kim, Seung Min Lee, Xuanyuan hanning, Hyun Sung Kim, Dae Won Jun, Eileen L. Yoon Digestive Diseases and Sciences.2024; 69(5): 1701. CrossRef
Hepatoprotective Effect of Kaempferol: A Review of the Dietary Sources, Bioavailability, Mechanisms of Action, and Safety Maulana Yusuf Alkandahri, Barolym Tri Pamungkas, Zulpakor Oktoba, Mareetha Zahra Shafirany, Lela Sulastri, Maya Arfania, Ebta Narasukma Anggraeny, Ade Pratiwi, Fitri Dwi Astuti, Indriyani, Siti Yuliani Dewi, Salsa Zulfa Hamidah, Srinivas Mutalik Advances in Pharmacological and Pharmaceutical Sciences.2023; 2023: 1. CrossRef
Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis Michael Nagel, Vanessa Weidner, Sina Schulz, Jens U. Marquardt, Peter R. Galle, Jörn M. Schattenberg, Marc Nguyen-Tat, Marcus-Alexander Wörns, Christian Labenz Health and Quality of Life Outcomes.2022;[Epub] CrossRef
Scoping review of managed alcohol programs Shannon M. Smith-Bernardin, Leslie W. Suen, Jill Barr-Walker, Isabel Arrellano Cuervo, Margaret A. Handley Harm Reduction Journal.2022;[Epub] CrossRef
First
Prev
